Cita APA (7a ed.)
He, K., Yang, Z., Liu, X., Yang, Y., Song, W., Wang, S., & Chen, Y. (2023). Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization. Current Oncology, 30(1), 476-492.
Cita Chicago Style (17a ed.)
He, Kun, Zelong Yang, Xinyu Liu, Yanling Yang, Wenjie Song, Shangyu Wang, y Yong Chen. "Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization." Current Oncology 30, no. 1 (2023): 476-492.
Cita MLA (9a ed.)
He, Kun, et al. "Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization." Current Oncology, vol. 30, no. 1, 2023, pp. 476-492.
Precaución: Estas citas no son 100% exactas.